Literature DB >> 1701221

Strong xenogeneic HLA response in transgenic mice after introducing an alpha 3 domain into HLA B27.

U Kalinke1, B Arnold, G J Hämmerling.   

Abstract

The pronounced response by mouse T cells to the major histocompatibility complex (MHC) class I antigens of the same species is characterized by a relatively large fraction of responding cells. Responses to MHC class I allelles of other species are, however, generally much weaker. T lymphocytes are positively selected on thymic MHC antigens, resulting in a T-cell repertoire with strong alloreactivity. This has been explained in terms of a mouse T-cell repertoire that is not efficiently selected for recognition of HLA molecules owing to the absence of HLA in mice. Here we show that mice transgenic for HLA mount a T-cell response against allogeneic HLA that is no better than in normal mice. We decided instead to test whether the mouse accessory molecule Lyt-2 on cytotoxic T lymphocytes could interact efficiently with the alpha 3 domain of HLA. To do this, we replaced the alpha 3 domain of HLA-B27 by a murine alpha 3 domain in a gene construct used to produce transgenic mice, and then used the spleen cells from these mice to stimulate normal mouse T cells. Under these conditions cytotoxic T lymphocytes were generated with the same frequency against xenogeneic HLA-B27 determinants as against allogeneic mouse class I antigens. These findings indicate that the normally weak xeno-MHC response is due to the inefficient interaction of the murine Lyt-2 accessory molecule with HLA class I, and not to limitations of the mouse T-cell repertoire.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701221     DOI: 10.1038/348642a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  19 in total

Review 1.  Transgenic models of autoimmune disease.

Authors:  R J Boyton; D M Altmann
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells.

Authors:  Elena Lorente; Susana Infantes; Eilon Barnea; Ilan Beer; Ruth García; Fátima Lasala; Mercedes Jiménez; Carlos Vilches; François A Lemonnier; Arie Admon; Daniel López
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

3.  Inhibition of B cell-dependent lymphoid follicle formation prevents lymphocytic bronchiolitis after lung transplantation.

Authors:  Natalia F Smirnova; Thomas M Conlon; Carmela Morrone; Peter Dorfmuller; Marc Humbert; Georgios T Stathopoulos; Stephan Umkehrer; Franz Pfeiffer; Ali Ö Yildirim; Oliver Eickelberg
Journal:  JCI Insight       Date:  2019-02-07

Review 4.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

5.  Hierarchy in the assembly of HLA-B27 and HLA-Cw3 molecules in transgenic mice.

Authors:  S Pedrinaci; J Hanson; C David
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.

Authors:  Rachid Boucherma; Hédia Kridane-Miledi; Romain Bouziat; Michael Rasmussen; Tanja Gatard; Francina Langa-Vives; Brigitte Lemercier; Annick Lim; Marion Bérard; Lbachir Benmohamed; Søren Buus; Ronald Rooke; François A Lemonnier
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

7.  Sharing of an HLA-B27-restricted H-Y antigen between rat and mouse.

Authors:  W A Simmons; J D Taurog; R E Hammer; M Breban
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

8.  Negative and positive selection by HLA-DR3(DRw17) molecules in transgenic mice.

Authors:  G Strauss; D A Vignali; G Schönrich; G J Hämmerling
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

9.  Recognition of HLA-B27 by mouse cytotoxic T-cell clones: a transgenic mouse model.

Authors:  M Reboul; B Frangoulis; A Rocca; L Degos; M Pla
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

10.  Mamu-A01/K(b) transgenic and MHC Class I knockout mice as a tool for HIV vaccine development.

Authors:  Jinliang Li; Tumul Srivastava; Ravindra Rawal; Edwin Manuel; Donna Isbell; Walter Tsark; Corinna La Rosa; Zhongde Wang; Zhongqi Li; Peter A Barry; Katharine D Hagen; Jeffrey Longmate; Don J Diamond
Journal:  Virology       Date:  2009-02-27       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.